Global Contract Research Organization (CRO) Services Market to Reach 9% CAGR Backed by Innovation by 2030
The global
contract research organization (CRO) services market is
expected to witness a growth rate of 9% in the next five years. Growing
R&D investments in pharmaceutical and biotechnology sectors; innovations in
therapeutic areas like oncology, and rare diseases; the need for
cost-efficiency & faster time-to-market; stringent regulatory
compliance/reporting, growing adoption of decentralized and virtual clinical
trials, and increasing complexity of drugs and clinical trials are some of the
key factors driving the CRO services market growth.
A contract research organization (CRO) provides
comprehensive clinical trial services for the pharmaceutical, biotechnology,
and medical device sectors. CRO services majorly include clinical research
services, early-phase development services, laboratory services, consulting
services, among others. Some of the typical reasons why the pharmaceutical,
biotechnology, and medical devices industries outsource to CROs include, better
return on R&D investments, lack of internal capabilities (esp. small biopharma
companies), increasing complexity in developing targeted therapeutic areas like
immuno-oncology therapies, stringent regulatory requirements, to focus on core
competencies, strategic choice, and time and cost-efficiency among others.
Unlock key findings! Fill out a quick inquiry to access a
sample report
https://meditechinsights.com/contract-research-organization-cro-services-market/request-sample/
Growing Investments from Governments, Private Companies,
and Venture Capitalists to Drive Market Growth
In recent years, fundings and investments in CRISPR
technology have been significant, showcasing the growing interest and support
for this innovative field. In February 2024, CRISPR Therapeutics secured
approximately USD 280 million through an agreement to sell its common shares to
a select group of institutional investors. This investment aims to accelerate
their gene-editing programs and expand their therapeutic pipeline. Another
notable example is the Indian biotechnology start-up CrisprBits, which raised
USD 250,000 in pre-seed funding from US-based VJ Group in February 2023. This
funding is intended for developing CRISPR-based diagnostics to detect pathogens
and antimicrobial resistance genes. Likewise, in July 2023, Pfizer Inc. made a
USD 25 million equity investment in Caribou Biosciences, Inc. a leading
clinical-stage CRISPR genome-editing biopharmaceutical company. These examples
highlight the substantial financial support and confidence in the potential of
CRISPR technology.
Market trend towards full-service CROs/one-stop-shop
model
The shift toward full-service CROs is driven by the
complexities of modern drug development. Biopharma companies prefer CROs that
offer end-to-end services, from pre-clinical research to commercialization,
ensuring streamlined processes, cost efficiency, and reduced timelines.
Full-service CROs provide scalable resources, specialized expertise, and global
reach, enabling seamless international trials and regulatory compliance. Their
ability to manage entire projects eliminates the need for multiple vendors,
improving efficiency. With advanced technologies and therapeutic expertise,
these CROs deliver high-quality outcomes, making them the preferred choice for
navigating the evolving drug development landscape and accelerating market
entry.
Competitive Landscape Analysis
The global contract research organization (CRO) services
market is marked by the presence of established and emerging market players
such as IQVIA, Labcorp, Syneos Health, Thermo Fisher Scientific,
Parexel, ICON, Charles River, WUXI Apptec, Pharmacon Beijing, and SGS; among
others. Some of the key strategies adopted by market players include new
service launches, strategic partnerships and collaborations, and geographic
expansion.
Get exclusive insights - download your sample report
today
https://meditechinsights.com/contract-research-organization-cro-services-market/request-sample/
Market Segmentation
This report by Medi-Tech Insights provides the size of
the global contract research organization (CRO) services market at
the regional- and country-level from 2023 to 2030. The report further
segments the market based on service type, therapy area, end user.
- Market
Size & Forecast (2023-2030), By Service Type, USD Million
- Clinical
Research Services
- By
Phase
- Phase
III
- Phase
II
- Phase
I
- Phase
IV
- By
Study Design
- Interventional
- Real
World Evidence (RWE)
- Early-phase
Development Services
- Chemistry,
Manufacturing and Controls Services
- Preclinical
Services
- Pharmacokinetics/
Pharmacodynamics Services
- Toxicology
Testing Services
- Other
Preclinical Services
- Discovery
Studies
- Laboratory
Services
- Analytical
Testing Services
- Physical
Characterization Services
- Raw
Material Testing Services
- Batch
Release Testing Services
- Stability
Testing Services
- Other
Analytical Testing Services
- Bioanalytical
Testing Services
- Consulting
Services
- Other
Services
- Market
Size & Forecast (2023-2030), By Therapy Area, USD Million
- Oncology
- Infectious
Diseases
- CVS
Disorders
- Neurology
- Vaccines
- Endocrinology
- Immunological
Disorders
- Mental
Health Disorders
- Dermatology
- Ophthalmology
- Others
- Market
Size & Forecast (2023-2030), By End User, USD Million
- Pharmaceutical
& Biotechnology Companies
- Medical
Device Companies
- Other
End Users
- Market
Size & Forecast (2023-2030), By Region, USD Million
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive intelligence,
market sizing and forecasting, pricing analysis & go-to-market strategy.
Our methodology includes rigorous secondary research combined with deep-dive
interviews with industry-leading CXO, VPs, and key demand/supply side
decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment